Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions

European Journal of Radiology

Volumn 73, Issue 2, 2010, Pages 288-293

  Zhao, Hongjia ^a   Xu, Rong ^a   Ouyang, Qiufang ^a   Chen, Lidian ^a   Dong, Baowei ^b   Huihua, Ye ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Breast neoplasm; Contrast enhanced ultrasound; Qontrast software; Time intensity curve

Indexed keywords

BEFORE AND AFTER; BENIGN AND MALIGNANT TUMORS; BENIGN TUMOR; BREAST LESION; BREAST NEOPLASM; BREAST TUMOR; COLOR MAP; CONTRAST AGENT; CONTRAST ENHANCED ULTRASOUND; CONTRAST MEDIUM; DIAGNOSTIC METHODS; DIFFERENTIAL DIAGNOSIS; INTENSITY SIGNAL; MALIGNANT LESION; MALIGNANT TUMORS; MILAN , ITALY; PARAMETRIC IMAGING; PEAK INTENSITY; QONTRAST SOFTWARE; SONOGRAPHIC; STATISTICALLY SIGNIFICANT DIFFERENCE; TIME TO PEAK; TIME-INTENSITY CURVES;

ACOUSTIC WAVES; COMPUTER SOFTWARE; CONTRAST MEDIA; DIAGNOSIS; ONCOLOGY; ULTRASONIC APPLICATIONS; ULTRASONICS;

TUMORS;

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST LESION; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PARAMETER; PRIORITY JOURNAL; ULTRASOUND;

ADULT; AGED; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; MIDDLE AGED; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY, MAMMARY;

EID: 76349100506     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.05.043     Document Type: Article

References (12)

1. Folkman J. Angiogenesis and breast cancer. J Clin Oncol 12 (1994) 441-443
2. Ricci P., Cantisani V., Ballesio L., et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med 28 1 (2007) 57-62
3. Barnard S., Leen E., Cooke T., and Angerson W. A contrast-enhanced ultrasound study of benign and malignant breast tissue. S Afr Med J 98 5 (2008) 386-391
4. Kettenbach J., Helbich T.H., Huber S., Zuna I., and Dock W. Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. Eur Radiol 53 2 (2005) 238-244
5. Hochmuth A., Boehm T., Bitzer C., Fleck M., Schneider A., and Kaiser W.A. Differentiation of breast masses using 3-D sonographic and echo-enhancer-based evaluation of the vascular pattern: initial experiences. Ultrasound Med Biol 28 7 (2002) 845-851
6. Tozaki M., Igarashi T., Matsushima S., et al. High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters. Radiat Med 23 1 (2005) 43-50
7. Teifke A., Lehr H.A., Vomweg T.W., et al. Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. AJR Am J Roentgenol 181 3 (2003) 655-662
8. Stuhrmann M., Aronius R., and Schietzel M. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography. AJR Am J Roentgenol 75 6 (2000) 1585-1589
9. Ozdemir A., Kilic K., Ozdemir H., et al. Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography. J Ultrasound Med 23 2 (2004) 183-195
10. Shubik P. Vascularization of tumors: a review. J Cancer Res Clin Oncol 103 (1982) 211-226
11. Menna S., Divirgilio M.R., and Burke P. Ultrasonography contrast media Levovist and power Doppler in the study of the breast: methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves. Radiol Med (Torino) 97 (1999) 472-478
12. Boyajian R.A., Otis S.M., Droste D.W., et al. Continuous infusion versus bolus injection of ultrasound contrast agents in vascular doppler flow imaging response. Stroke 31 9 (2000) 2266-2278